"Usually in Phase III clinical trials, which then leads to regulatory approval and widespread adoption of the new treatment as the new standard of care for that specific cancer type" which is what I said and irrelevant whether regulatory approval is gained from registrational clinical trial, i.e. Ph2/3, or from Ph3 clinical trial.
IMU Price at posting:
3.9¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)